Treatment of full thickness cartilage lesions with a 3D Printed Nanochon Implant in an Equine model
Charlotte K Barton BVSc, MS, DACVS-LA, MS, MS, Katie A Seabaugh DVM, MS, DACVS-LA, DACVSMR, Ben Gadomski BS, PhD, Kevin […]
Abstract
News
2025 Third Quarter Update
Nanochon has secured commitments to close oversubscribed convertible note, bringing our total capital raised to date to $11.3 million. While the majority of this bridge was filled by current investors, we’re thrilled to welcome a few new folks onto our cap table.
News
The Maryland Stem Cell Research Commission Awards Nanochon Grant Funding
The Maryland Stem Cell Research Commission, the body overseeing The Maryland Stem Cell Research Fund (MSCRF), has awarded Nanochon grant
Press Release
Nanochon Announces Health Canada Approval for First in Human Investigation
Washington, DC, July 14 2025 – Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant
News
Nanochon Creating a New Clinical Standard for Cartilage Restoration
Under the direction of CEO Benjamin Holmes, Nanochon, Inc. is set to revolutionize the treatment of cartilage loss and damage.
News
LaunchPort Welcomes Nanochon
LaunchPort is pleased to announce that Nanochon has joined their City Garage/Baltimore Peninsula location as a LaunchPort Resident. “Over the
Press Release
Nanochon Named to MedTech Innovator 2024 Cohort
LOS ANGELES-MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced its 2024 Accelerator Cohort. After a competitive selection
Press Release
Nanochon closes $4M Series Seed Prime
WASHINGTON–Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round. The
News
3D Natives Interview with Nathan Castro
Founded in 2016, Nanochon aims to facilitate cartilage replacement and repair for patients suffering from knee injuries. It relies on
Press Release
cultivate(MD) Capital Funds LP Announce Investment into Nanochon
Grand Rapids, Mich., November 27, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies